CSL Limited (CSLLY)

OTC Markets OTCQX Currently down 0.65 (-3.12%) in today's trading session

1 member of Congress has disclosed 4 trades in CSL Limited (CSLLY) via STOCK Act filings. The most recent disclosure was a sale by Josh Gottheimer on 30 November 2018. Aggregate disclosed activity totals roughly $32K in sales (midpoint estimates from bracketed disclosure amounts).

CSL Limited is currently trading at $20.15, positioned at 14% of its 52-week range ($16.01 – $44.85).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Free asset at sign up • Eligible regions only
Live portfolio tracking
Automatic rebalancing

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Not available in the US.

Past Performance is not an indication of future results.

*Free asset promotion available at sign up in eligible regions only. Terms and conditions apply.

Current Price
$20.15
24h Change
-0.65 (-3.12%)
52 Week Range
$16.01$44.85
View on NASDAQ

CSL Limited Price History and Technical Analysis

Interactive Chart

Congressional Trading Activity for CSLLY

Select to highlight on chart
0 transactions
Compliance: 0%
No data

Select transactions to view their annotations on the chart

Stock Overview

Market Data

Market Cap

$78.03B

Volume

8.04K

Beta

0.08

P/E Ratio

35.29

Fundamentals

EPS

$0.57

Div. Yield

3.59%

Open

$20.08

Day Range

$20.01 — $20.17

Company Information

Sector
Healthcare
Industry
Biotechnology
Exchange
OTC · USD
Country
AU
CEO
Gordon Naylor DipCompSc
IPO Date
2009-12-29

CSL Limited is a global biopharmaceutical enterprise dedicated to the research, development, production, marketing, and distribution of a wide array of biopharmaceutical and related healthcare products. The company boasts a significant international...

Earnings

Recent Quarters

Q4 20258 Feb
EPS$0.06
Q2 202519 Aug
EPS
Q4 202411 Feb
EPS$0.52
Q3 202430 Oct
EPS$2.03
Q2 202413 Aug
EPS$0.19
Q1 202411 Apr
EPS$0.51
Q1 202411 Apr
EPS$0.76
Q4 202313 Feb
EPS$1.95
Q1 202330 Jun
EPS$0.15
Q4 202231 Mar
EPS$0.59
Q3 202231 Dec
EPS$0.43
Q2 202230 Sept
EPS$1.70
Q1 202230 Jun
EPS$0.11
Q4 202131 Mar
EPS$0.51
Q3 202131 Dec
EPS$0.48
Q2 202130 Sept
EPS$1.92
Q1 202130 Jun
EPS$0.10
Q4 202031 Mar
EPS$0.62
Q3 202031 Dec
EPS$0.35
Q2 202030 Sept
EPS$1.99
Q1 202030 Jun
EPS$0.19
Q4 201931 Mar
EPS$0.93
Q3 201931 Dec
EPS$0.25
Q2 201930 Sept
EPS$1.37
Q1 201930 Jun
EPS$0.21
Q4 201831 Mar
EPS$0.83
Q3 201831 Dec
EPS$0.32
Q2 201830 Sept
EPS$1.28
Q1 201830 Jun
EPS$0.24
Q4 201731 Mar
EPS$0.71
Q3 201731 Dec
EPS$0.38
Q2 201730 Sept
EPS$1.20
Q1 201730 Jun
EPS$0.19
Q4 201631 Mar
EPS$0.58
Q3 201631 Dec
EPS$0.31
Q2 201630 Sept
EPS$0.88
Q1 201630 Jun
EPS$0.19
Q4 201531 Mar
EPS$0.56
Q3 201531 Dec
EPS$0.27
Q2 201530 Sept
EPS$0.77
Q1 201530 Jun
EPS$0.24
Q4 201431 Mar
EPS$0.73
Q3 201431 Dec
EPS$0.22
Q2 201430 Sept
EPS$0.73
Q1 201430 Jun
EPS$0.18
Q4 201331 Mar
EPS$0.68
Q3 201331 Dec
EPS$0.19
Q1 201330 Jun
EPS$0.08
Q3 201230 Dec
EPS$0.20
Q1 201230 Jun
EPS$0.12
Q3 201130 Dec
EPS$0.12
Q1 201130 Jun
EPS$0.12
Q3 201030 Dec
EPS$0.12
Q1 201030 Jun
EPS$0.08
Q3 200930 Dec
EPS$0.08
Q1 200930 Jun
EPS$0.08
Q3 200830 Dec
EPS$0.08
Q1 200830 Jun
EPS$0.07
Q3 200730 Dec
EPS$0.07
Q1 200730 Jun
EPS$0.04
Q3 200630 Dec
EPS$0.04
Q1 200630 Jun
EPS$0.01
Q3 200530 Dec
EPS$0.01
Q1 200530 Jun
EPS$0.03
Q3 200430 Dec
EPS$0.03
Q1 200430 Jun
EPS$0.01
Q3 200330 Dec
EPS$0.01
Q1 200330 Jun
EPS$0.00
Q3 200230 Dec
EPS$0.00
Q1 200230 Jun
EPS$0.01
Q3 200130 Dec
EPS$0.01
Q1 200130 Jun
EPS$0.00
Q3 200030 Dec
EPS$0.00
Q1 200030 Jun
EPS$0.00
Q3 199930 Dec
EPS$0.00
Q1 199930 Jun
EPS$0.00
Q3 199830 Dec
EPS$0.00
Q1 199830 Jun
EPS$0.00
Q3 199730 Dec
EPS$0.00
Q1 199730 Jun
EPS$0.00
Q3 199630 Dec
EPS$0.00
Q1 199630 Jun
EPS$0.01
Q1 199630 Jun
EPS$0.01
Q1 199530 Jun
EPS$0.00
Q3 199430 Dec
EPS$0.00
Q1 199430 Jun
EPS$0.00
Q3 199330 Dec
EPS$0.00
Q1 199330 Jun
EPS$0.00
Q3 199230 Dec
EPS$0.00

Dividends

Dividend History

11 Mar 2026
Amount $0.3192
10 Sept 2025
Amount $0.4050
11 Mar 2025
Amount $0.3250
10 Sept 2024
Amount $0.3625
11 Mar 2024
Amount $0.2975
8 Sept 2023
Amount $0.3225
8 Mar 2023
Amount $0.2675
2 Sept 2022
Amount $0.2950
4 Mar 2022
Amount $0.2600
1 Sept 2021
Amount $0.2950
3 Mar 2021
Amount $0.2600
9 Sept 2020
Amount $0.2675
10 Mar 2020
Amount $0.2375
9 Sept 2019
Amount $0.2463
14 Mar 2019
Amount $0.2125
10 Sept 2018
Amount $0.4047
13 Mar 2018
Amount $0.1975
11 Sept 2017
Amount $0.1799
13 Mar 2017
Amount $0.1582
9 Sept 2016
Amount $0.1678
21 Mar 2016
Amount $0.1566
3 Sept 2015
Amount $0.1578
13 Mar 2015
Amount $0.1422
5 Sept 2014
Amount $0.1405
7 Mar 2014
Amount $0.1359
10 Sept 2013
Amount $0.1338
7 Mar 2013
Amount $0.1260
18 Sept 2012
Amount $0.1201
15 Mar 2012
Amount $0.0929
20 Sept 2011
Amount $0.1142
10 Mar 2011
Amount $0.0921
14 Sept 2010
Amount $0.1020
10 Mar 2010
Amount $0.0790
15 Sept 2009
Amount $0.0904
11 Mar 2009
Amount $0.0539

Stock Splits

Split History

2 Mar 2026Stock Split
Ratio2:1

Similar Stocks

Based on congressional trading patterns

Smart Recommendations
No similar stocks found
No congressional trading patterns available for recommendations

Frequently Asked Questions about CSLLY

Which members of Congress have traded CSLLY?
1 member of Congress has disclosed 4 trade in CSL Limited (CSLLY) under the STOCK Act: Josh Gottheimer.
When was CSLLY most recently disclosed by Congress?
The most recent CSLLY disclosure was a sale by Josh Gottheimer on 30 November 2018.
What is the total disclosed congressional trading volume for CSLLY?
Members of Congress have disclosed approximately $32K in CSLLY sales (midpoint estimate derived from the bracketed amount ranges used in STOCK Act filings).
How can I track new congressional trades in CSLLY?
This CSLLY page updates as soon as new STOCK Act disclosures are filed for CSL Limited. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
© 2026 - All rights reserved. Powered by Vantara Labs
This website is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office, or her representatives. Any use of her name is solely for the purpose of discussing publicly available information.The information provided on this website is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.